Literature DB >> 17164916

Per(6-guanidino-6-deoxy)cyclodextrins: synthesis, characterisation and binding behaviour toward selected small molecules and DNA.

Nikolaos Mourtzis1, Kyriaki Eliadou, Chrysie Aggelidou, Vassiliki Sophianopoulou, Irene M Mavridis, Konstantina Yannakopoulou.   

Abstract

Per(6-guanidino-6-deoxy)-cyclodextrins , and are novel derivatives, resulting from homogeneous introduction of the guanidino group at the primary side of alpha-, beta- and gamma-cyclodextrins. The products were obtained from the corresponding amino derivatives, as direct guanidinylation of the known bromo-cyclodextrins provided mixtures. The new compounds were fully characterized by NMR spectroscopy and other analytical methods, and their interaction with guest molecules was studied. Strong complexation with 4-nitrophenyl phosphate () disodium salt was observed (K(binding) approximately 5 x 10(4) M(-1)), whereas the non-phosphorylated substrate nitrobenzene () formed a very weak complex. 2D ROESY spectra revealed cavity inclusion in both cases, however the orientation of was opposite to that of , such that the phosphate group is oriented toward the primary side facing the guanidine groups. The strong affinity of towards the phosphorylated guest suggested that interaction with DNA was possible. The new compounds were found to completely inhibit the migration of ultra pure calf thymus DNA during agarose gel electrophoresis, whereas no effects were observed with guanidine alone or with the plain cyclodextrins. Further, the condensation of DNA into nanoparticles in the presence of was demonstrated by atomic force microscopy, confirming strong electrostatic interaction between the biopolymer and the multicationic products . The strong guanidine-phosphate interactions between and DNA were therefore attributed to the clustering of the guanidine groups in the primary area of the cyclodextrin. Cavity effects could not be assessed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164916     DOI: 10.1039/b614899a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Symmetry requirements for effective blocking of pore-forming toxins: comparative study with alpha-, beta-, and gamma-cyclodextrin derivatives.

Authors:  Konstantina Yannakopoulou; Laszlo Jicsinszky; Crysie Aggelidou; Nikolaos Mourtzis; Tanisha M Robinson; Adiamseged Yohannes; Ekaterina M Nestorovich; Sergey M Bezrukov; Vladimir A Karginov
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

3.  Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.

Authors:  Violeta Rodriguez-Ruiz; Andrey Maksimenko; Giuseppina Salzano; Maria Lampropoulou; Yannis G Lazarou; Valentina Agostoni; Patrick Couvreur; Ruxandra Gref; Konstantina Yannakopoulou
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Development of Dipicolylamine-Modified Cyclodextrins for the Design of Selective Guest-Responsive Receptors for ATP.

Authors:  Tatsuru Yamada; Shoji Fujiwara; Kyohhei Fujita; Yuji Tsuchido; Takeshi Hashimoto; Takashi Hayashita
Journal:  Molecules       Date:  2018-03-12       Impact factor: 4.411

5.  A Quinoline-Appended Cyclodextrin Derivative as a Highly Selective Receptor and Colorimetric Probe for Nucleotides.

Authors:  Kuppusamy Kanagaraj; Chao Xiao; Ming Rao; Chunying Fan; Victor Borovkov; Guo Cheng; Dayang Zhou; Zhihui Zhong; Dan Su; Xingke Yu; Jiabin Yao; Taotao Hao; Wanhua Wu; Jason J Chruma; Cheng Yang
Journal:  iScience       Date:  2020-02-21

6.  Lipase mimetic cyclodextrins.

Authors:  Youngjun Lee; Neal K Devaraj
Journal:  Chem Sci       Date:  2020-11-19       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.